Author:
Yamamoto M,Shimura S,Itoh Y,Ohsaka T,Egawa M,Inoue S
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)
Reference21 articles.
1. Borgstöm B . Luminal digestion of fats. In Go L (ed.) The exocrine pancreas: biology, pathobiology and diseases Raven Press: New York 1986 pp 361–373.
2. Hadváy P, Lengsfeld H, Wolfer H . Inhibition of pancreatic lipase in vitro by covalent inhibitor tetrahydrolipstatin Biochem J 1988 256: 357–361.
3. Drent ML, Larsson I, William-Olsson T, Quaade F, Czubayko F, Von Bergmann K, Strobel W, Sjöström L, Van der Veen EA . Orlistat (RO 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study Int J Obes Relat Metab Disord 1995 19: 221–226.
4. Hauptman JB, Jeunet FS, Hartmann D . Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin) Am J Clin Nutr 1992 55: 309S–313S.
5. Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HPF . Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients Lancet 1998 352: 167–172.
Cited by
91 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献